01244 3D MEDICINES
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.02X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 3.2% | Net Margin | N/A |
Total Debt/Equity | 30.3% | Return on Equity | N/A |
Price/Book | 1.73X | Return on Assets | N/A |
(HKD 5.600) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -194.26 | -578.32 | -1,148.50 | -1,754.04 | -754.07 |
---|---|---|---|---|---|
Net Profit Growth (%) | +66.4 | +49.7 | +34.5 | -132.6 | N/A |
Earnings Per Share (HKD) | -0.793 | -2.531 | -25.248 | -44.917 | -16.537 |
Earnings Per Share Growth (%) | +68.7 | +90.0 | +43.8 | -171.6 | N/A |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 3.234 | 3.999 | 4.136 | N/A | N/A |
Auditors' Opinion | Unqualified # | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 445.647 | 634.949 | -29.8 | 567.392 |
Operating Result | -199.378 | -562.466 | -64.6 | -1,052 |
Profit Before Taxation | -199.378 | -562.466 | -64.6 | -1,052 |
Taxation | 0 | 0.055 | -100.0 | 0 |
Profit /( Loss) After Taxation | -199.378 | -562.521 | -64.6 | -1,052 |
Minority Interests | -16.715 | -37.824 | -55.8 | -27.68 |
Net Profit | -182.663 | -524.697 | -65.2 | -1,024 |
Earnings Per Share () | -0.7930 | -2.5313 | -68.7 | -25.2484 |
Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25